At GBF Strategy, we specialise in bridging the gap between groundbreaking MedTech innovations and successful commercialisation. With over two decades of expertise in medical imaging and medical device development, we deliver tailored strategies that turn proven technologies into market-leading solutions.
Led by Dr Gordon McKenzie, an expert in medical imaging, AI applications, and MedTech commercialisation, GBF Strategy offers deep strategic insight backed by a network of scientific, commercial, and regulatory specialists who are brought in as needed.
Gordon’s extensive experience includes developing and launching transformational technologies. Some examples include
Michelson Diagnostics: Co-founder and Director of Clinical Development for the OCT technology commercialisation programme.
Intelligent Ultrasound: Created AI-driven value propositions and pilots that resulted in a major OEM licensing deal for obstetric ultrasound AI.
Sēon Diagnostics: Served as interim CEO during its corporate restructuring.
VivaScope GmbH: Clinical consultant for the UK specialising in confocal microscopy.
GBF Strategy operates in two areas: Business Support and Clinical Support.
Business Support
Value Proposition Development: Craft compelling, evidence-based business cases.
Seed and Growth Strategy: Lay strong foundations for market entry and scaling.
Business Planning and Investment Readiness: Position for funding success.
Technology Evaluation and Integration: Assess and integrate cutting-edge technologies.
Marketing Support: Build strategies that resonate with target markets.
Clinical Support
Literature Surveys and Feasibility Assessments: Evaluate evidence for clinical and market potential.
Medical and MedTech Writing: Develop clear, impactful documentation.
Early-Stage Clinical Management: Plan and manage clinical pilots with precision.
Key Opinion Leader Engagement: Recruit and manage influential stakeholders.
Clinical Trial Planning and Implementation: Navigate the complexities of trial design and execution.